Eliem Therapeutics EVP sells $338,000 in stock By Investing.com
Valerie Morissette, Executive Vice President of Research and Development and Chief Scientific Officer of Eliem Therapeutics, Inc. (NASDAQ:ELYM), sold a significant number of shares of the company. On July 3, 2024, Morissette disposed of…